A Justice Department probe of possible price collusion by generic drug companies could lead to criminal charges by the end of the year, Bloomberg News reported Thursday.

The investigation spans more than a dozen companies, Bloomberg reported, citing people familiar with the matter.

Shares of several generic drug makers declined following the report. Among them were Lannett Co. (LCI), which fell 26% to $17.30, Endo International PLC (ENDP), which was down 18% to $14.85 and Teva Pharmaceutical Industries Ltd. (TEVA), down 12% to $38.02.

Full story at http://www.bloomberg.com/news/articles/2016-11-03/u-s-charges-in-generic-drug-probe-said-to-be-filed-by-year-end

Write to nymonitoring@dowjones.com

(END) Dow Jones Newswires

November 03, 2016 15:53 ET (19:53 GMT)

Copyright (c) 2016 Dow Jones & Company, Inc.
Impax labs (NASDAQ:IPXLE)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025 Impax labs 차트를 더 보려면 여기를 클릭.
Impax labs (NASDAQ:IPXLE)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025 Impax labs 차트를 더 보려면 여기를 클릭.